- Home
- PYPD vs GROV Comparison
PYPD vs GROV Comparison
Compare PYPD & GROV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYPD
- GROV
- Stock Information
- Founded
- PYPD 2008
- GROV 2016
- Country
- PYPD Israel
- GROV United States
- Employees
- PYPD N/A
- GROV N/A
- Industry
- PYPD Medical/Dental Instruments
- GROV Package Goods/Cosmetics
- Sector
- PYPD Health Care
- GROV Consumer Discretionary
- Exchange
- PYPD Nasdaq
- GROV Nasdaq
- Market Cap
- PYPD 54.7M
- GROV 64.0M
- IPO Year
- PYPD 2020
- GROV N/A
- Fundamental
- Price
- PYPD $3.80
- GROV $1.32
- Analyst Decision
- PYPD Strong Buy
- GROV Buy
- Analyst Count
- PYPD 5
- GROV 2
- Target Price
- PYPD $12.00
- GROV $1.35
- AVG Volume (30 Days)
- PYPD 92.7K
- GROV 90.7K
- Earning Date
- PYPD 11-12-2025
- GROV 11-07-2025
- Dividend Yield
- PYPD N/A
- GROV N/A
- EPS Growth
- PYPD N/A
- GROV N/A
- EPS
- PYPD N/A
- GROV N/A
- Revenue
- PYPD N/A
- GROV $185,354,000.00
- Revenue This Year
- PYPD N/A
- GROV N/A
- Revenue Next Year
- PYPD N/A
- GROV $11.10
- P/E Ratio
- PYPD N/A
- GROV N/A
- Revenue Growth
- PYPD N/A
- GROV N/A
- 52 Week Low
- PYPD $2.30
- GROV $1.02
- 52 Week High
- PYPD $3.93
- GROV $1.95
- Technical
- Relative Strength Index (RSI)
- PYPD 68.11
- GROV 37.72
- Support Level
- PYPD $3.10
- GROV $1.23
- Resistance Level
- PYPD $3.50
- GROV $1.50
- Average True Range (ATR)
- PYPD 0.18
- GROV 0.08
- MACD
- PYPD 0.06
- GROV -0.03
- Stochastic Oscillator
- PYPD 94.87
- GROV 26.47
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
About GROV Grove Collaborative Holdings Inc.
Grove Collaborative Holdings Inc is engaged in providing consumer products. It offers Cleaning accessories, Home and Pantry, Personal care products, Pets supplements and Other products. It is a sustainability oriented consumer products generator. It use connection with consumers to create and curate authentic, disruptive brands and products. Company builds natural products that perform as well as, many consumer packaged goods (CPG) brands (both conventional and natural), while being healthier for consumers and the planet.